St. Luke's Mid America Heart Institute, Kansas City (United States of America)
52
presentations
6
followers
4
more
presentations
in this session
PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event